1. Emerging agents for the treatment of metastatic urothelial cancer
    Whi-An Kwon et al, 2021, Investigative and Clinical Urology CrossRef
  2. BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression
    Se Kim et al, 2018, International Journal of Molecular Sciences CrossRef
  3. Monoinstitutional real world experience in management of Vinflunine as second line therapy for transitional cell carcinoma of the urothelium
    Giovanni Schinzari et al, 2018, Oncotarget CrossRef
  4. Comparison of efficacy and toxicity of second-line combination chemotherapy regimens in patients with advanced urothelial carcinoma
    Yuji Takeyama et al, 2018, International Journal of Clinical Oncology CrossRef
  5. Use of oral paclitaxel for the treatment of bladder tumors in dogs
    Hyung-Kyu CHAE et al, 2020, Journal of Veterinary Medical Science CrossRef
  6. Current Systemic Treatment Options in Metastatic Urothelial Carcinoma after Progression on Checkpoint Inhibition Therapy—A Systemic Review Combined with Single-Group Meta-Analysis of Three Studies Testing Enfortumab Vedotin
    Susanne Deininger et al, 2021, Cancers CrossRef
  7. Preclinical studies for the combination of paclitaxel and curcumin in cancer therapy
    Yumeng Wei et al, 2017, Oncology Reports CrossRef
  8. Medical Image Diagnostic Value of Computed Tomography for Bladder Tumors
    Lin Li et al, 2021, Computational and Mathematical Methods in Medicine CrossRef
  9. ABT-751 Induces Multiple Anticancer Effects in Urinary Bladder Urothelial Carcinoma-Derived Cells: Highlighting the Induction of Cytostasis through the Inhibition of SKP2 at Both Transcriptional and Post-Translational Levels
    Seyedeh Zahra Dehghanian et al, 2021, International Journal of Molecular Sciences CrossRef
  10. Pseudoprogression or unexpected favorable response to third-line therapy: a challenging metastatic bladder cancer case
    Adriana Soares et al, 2020, Porto Biomedical Journal CrossRef
  11. Inhibition of REDD1 Sensitizes Bladder Urothelial Carcinoma to Paclitaxel by Inhibiting Autophagy
    Qinghai Zeng et al, 2018, Clinical Cancer Research CrossRef
  12. Modern possibilities of organ-preserving treatment of patients with muscle-invasive bladder cancer
    Vladimir J. Startsev et al, 2019, Urologicheskie vedomosti CrossRef
  13. Review of Curcumin Physicochemical Targeting Delivery System

    Lanmei Li et al, 2020, International Journal of Nanomedicine CrossRef
  14. Bladder Cancer
    Surya K. De, 2022, Fundamentals of Cancer Detection, Treatment, and Prevention CrossRef